DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
06 nov 2012 - 07:35
Statutaire naam
DSM B.V.
Titel
DSM reports solid Q3 results despite weak economic conditions
Bericht
-Q3 EBITDA from continuing operations €270 million (Q3 2011: €339 million)
-Life Sciences, driven by Nutrition, showed good performance, representing 76% of Q3 EBITDA
-Materials Sciences continued to perform well, except for caprolactam
-Further strategic progress with acquisitions
-Strong Q3 cash flow from operating activities of €253 million
-Outlook 2012 largely unchanged
Datum laatste update: 08 november 2024